CAMBRIDGE, United Kingdom, March 7, 2005 (PRIMEZONE) -- Astex Technology Ltd:
-- Astex Technology, the fragment-based drug discovery and development
company, today announced the appointment of Neil Gallagher, MD PhD,
as Director of Clinical Development
-- Dr. Gallagher will be responsible for implementing clinical plans
for the development of Astex's pipeline of novel drug candidates,
the first of which is targeted to enter Phase I clinical trials
later this year
-- His excellent track record in clinical development and translational
research in oncology at AstraZeneca will help to accelerate the
clinical development of Astex's portfolio of molecularly-targeted
oncology drugs
Full press release attached below: http://hugin.info/132636/R/983096/146295.pdf